Natixis’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,500
Closed -$82.7K 1049
2023
Q4
$82.7K Buy
+7,500
New +$82.7K ﹤0.01% 769